HI HB1794 | 2022 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 24 2022 - 25% progression, died in committee
Action: 2022-02-17 - Report adopted. referred to the committee(s) on CPC as amended in HD 2 with Representative(s) Kapela voting aye with reservations; none voting no (0) and none excused (0).
Pending: House Consumer Protection & Commerce Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on January 24 2022 - 25% progression, died in committee
Action: 2022-02-17 - Report adopted. referred to the committee(s) on CPC as amended in HD 2 with Representative(s) Kapela voting aye with reservations; none voting no (0) and none excused (0).
Pending: House Consumer Protection & Commerce Committee
Text: Latest bill text (Amended) [HTML]
Summary
Requires DOH to implement standardized quality metrics to track and address health care processes or outcomes applicable to improving the quality of care for patients having opioid use disorders and targeting through value-based purchasing improvements in outcomes for patients having opioid use disorders by 7/1/2024. Requires DOH to implement value-based purchasing based on the standardized quality metrics by 1/1/2025. Directs DOH to collect certain data regarding opioid use. Requires annual reports to the legislature. Establishes a working group to determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care. Effective 7/1/2112. (HD2)
Title
Relating To Opioids.
Sponsors
Rep. Ryan Yamane [D] |
Roll Calls
2022-02-15 - House - House Health, Human Services, & Homelessness: Passed, With Amendments (Y: 6 N: 0 NV: 0 Abs: 1) [PASS]
2022-02-04 - House - House Government Reform: Passed, With Amendments (Y: 8 N: 0 NV: 0 Abs: 1) [PASS]
2022-02-04 - House - House Government Reform: Passed, With Amendments (Y: 8 N: 0 NV: 0 Abs: 1) [PASS]
History
Date | Chamber | Action |
---|---|---|
2022-02-17 | House | Report adopted. referred to the committee(s) on CPC as amended in HD 2 with Representative(s) Kapela voting aye with reservations; none voting no (0) and none excused (0). |
2022-02-17 | House | Reported from HHH (Stand. Com. Rep. No. 536-22) as amended in HD 2, recommending referral to CPC. |
2022-02-15 | House | The committees on HHH recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 6 Ayes: Representative(s) Yamane, Tam, Gates, Har, Kapela, Nishimoto; Ayes with reservations: none; 0 Noes: none; and 1 Excused: Representative(s) Ward. |
2022-02-10 | House | Bill scheduled to be heard by HHH on Tuesday, 02-15-22 9:00AM in House conference room 329 Via Videoconference. |
2022-02-09 | House | Passed Second Reading as amended in HD 1 and referred to the committee(s) on HHH with Representative(s) Kapela voting aye with reservations; none voting no (0) and Representative(s) Luke, McDermott excused (2). |
2022-02-09 | House | Reported from GVR (Stand. Com. Rep. No. 137-22) as amended in HD 1, recommending passage on Second Reading and referral to HHH. |
2022-02-04 | House | The committees on GVR recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) McKelvey, Wildberger, Cullen, Eli, Ichiyama, Mizuno, Woodson, Yamashita; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Ward. |
2022-02-02 | House | Bill scheduled for decision making on Friday, 02-04-22 9:30AM in conference room 309 Via Videoconference. |
2022-02-02 | House | The committee(s) on GVR recommend(s) that the measure be deferred until 02-04-22 9:30AM. |
2022-01-28 | House | Bill scheduled to be heard by GVR on Wednesday, 02-02-22 9:30AM in House conference room 309 Via Videoconference. |
2022-01-26 | House | Referred to GVR, HHH, CPC, referral sheet 2 |
2022-01-24 | House | Introduced and Pass First Reading. |
2022-01-21 | House | Pending introduction. |
Subjects
DOH
Opioids
Patient Outcomes
Standardized Metrics
Substance Use Disorder
Value-Based Purchasing
Working Group
Opioids
Patient Outcomes
Standardized Metrics
Substance Use Disorder
Value-Based Purchasing
Working Group